阿霉素市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00011780
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Doxorubicin Market Strategic Insights and Updates by 2031

Buy Now

预计到 2031 年,阿霉素市场规模将从 2023 年的 14.7 亿美元增至 23.5 亿美元。预计 2023-2031 年期间市场复合年增长率6.1%。仿制药获批率的提高可能仍是阿霉素市场的一个主要趋势。

阿霉素市场分析

化疗偏好增加和癌症发病率上升等因素推动了市场的增长。此外,政府对癌症预防的资金、指导和技术援助不断增加,为阿霉素市场参与者的未来增长提供了重要机会。

阿霉素市场概览

阿霉素用于化疗,治疗多种癌症,包括膀胱癌、乳腺癌、淋巴瘤等。它与其他化疗药物一起静脉注射,并以各种品牌名称销售,包括阿霉素Caelyx等。阿霉素是一种常用的蒽环类 化疗药物,可抑制癌细胞的发展。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

阿霉素市场:

阿霉素市场

  • 复合年增长率(2023 - 2031)
    6.1%
  • 2023 年市场规模
    14.7 亿美元
  • 2031 年市场规模
    23.5 亿美元

市场动态

增长动力
  • 癌症发病率不断上升
  • 化疗越来越受到青睐
未来的趋势
  • 纳米材料在癌症治疗中的应用是市场见证的新趋势
机会
  • 增加政府资金和补助

关键人物;主力;重要一员

  • 雅阁医疗
  • 西普拉公司
  • 雷迪博士实验室
  • 明治控股株式会社
  • 杨森制药(强生服务公司)
  • 诺华公司
  • 辉瑞公司
  • 太阳制药工业有限公司
  • 百特国际公司
  • 卡迪拉

区域概况

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

药物配方
  • 冻干粉
  • 阿霉素注射液
应用
  • 乳腺癌
  • 肾癌
  • 肝癌
  • 肉瘤
  • 卵巢癌
  • 肺癌
  • 白血病
  • 多发性骨髓瘤
分销渠道
  • 医院药房
  • 零售药店
  • 网上药店
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

阿霉素市场驱动因素和机遇

化疗偏好增加有利于市场增长

抗癌药物支出是产生额外医疗费用的关键。靶向治疗和化疗都显著提高了癌症患者的生存机会。这些疗法可能会完全缩小肿瘤。由于其好处,全球对化疗的需求激增。根据《柳叶刀肿瘤学》发表的一篇文章,从 2018 年到 2040 年,需要化疗的患者数量将增加 53%。晚期癌症治疗可提高患者生存率,并增加长期门诊化疗需求。更多地接触化疗会导致对阿霉素药物的需求增加,从而促进市场增长。

增加政府资金和补助,创造未来显著机遇

各国已启动多项计划,以有效、快速地治疗癌症。例如,2020 年 6 月,密苏里大学医学院从美国国立卫生研究院获得了近 350 万美元的资助,用于研究一种化疗前治疗,以保护癌症患者免受治疗引起的心脏并发症的影响。因此,政府的资助和援助不断增加,为阿霉素药物制造商提供了巨大的增长机会。

阿霉素市场报告细分分析

有助于得出阿霉素市场分析的关键部分是药物配方、应用和分销渠道。

  • 根据药物剂型,市场分为冻干粉和阿霉素注射剂。2023 年,冻干粉市场占据了更大的市场份额。
  • 根据应用,阿霉素市场细分为肺癌、肉瘤、乳腺癌、多发性骨髓瘤、卵巢癌、肾癌白血病、肝癌等。2023 年,乳腺癌领域占据了最大的市场份额。预计肾癌领域在预测期内的复合年增长率最高。
  • 就分销渠道而言,市场分为医院药房、零售药房和网上药房。2023 年,医院药房市场占据了相当大的市场份额。

阿霉素市场份额地域分析

阿霉素市场报告的地理范围涵盖五个地区:北美、亚太地区、欧洲、中东和非洲以及南美和中美。2023 年,北美占据了阿霉素市场的主导地位。制药行业的持续增长、各种癌症患病率的上升以及主要参与者不断增加的研发计划是北美阿霉素市场的驱动因素,这些因素推动了该地区市场的扩张。

阿霉素市场报告范围

报告属性细节
2023 年的市场规模14.7亿美元
2031 年市场规模23.5亿美元
全球复合年增长率(2023 - 2031)6.1%
历史数据2021-2022
预测期2024-2031
涵盖的领域按药物配方
  • 冻干粉
  • 阿霉素注射液
按应用
  • 乳腺癌
  • 肾癌
  • 肝癌
  • 肉瘤
  • 卵巢癌
  • 肺癌
  • 白血病
  • 多发性骨髓瘤
按分销渠道
  • 医院药房
  • 零售药店
  • 网上药店
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 雅阁医疗
  • 西普拉公司
  • 雷迪博士实验室
  • 明治控股株式会社
  • 杨森制药(强生服务公司)
  • 诺华公司
  • 辉瑞公司
  • 太阳制药工业有限公司
  • 百特国际公司
  • 卡迪拉
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

阿霉素市场新闻及最新动态

通过收集初步和二次研究后的定性和定量数据来评估阿霉素市场,其中包括重要的公司出版物、协会数据和数据库。以下是市场中的一些关键发展:

  • Zydus Cadila 已获得美国食品药品监督管理局的最终批准,可以销售盐酸阿霉素脂质体注射液 (US RLD:Doxil 脂质体注射液),其单剂量瓶装规格为 20 mg/10 mL (2 mg/mL) 和 50 mg/25 mL (2 mg/mL)。 (f Zydus Cadila,新闻稿,2020 年 9 月)

阿霉素市场报告覆盖范围和交付成果

“阿霉素市场规模和预测(2021-2031)”报告对市场进行了详细分析,涵盖以下领域:

  • 根管治疗市场规模及全球、区域和国家层面所有主要细分市场的预测
  • 根管治疗市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 根管市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,包括市场集中度、热图分析、知名参与者以及阿霉素市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the doxorubicin market in 2023?

North America dominated the market in 2023.

What are the factors driving the doxorubicin market growth?

Increasing prevalence of cancer and increasing preference for chemotherapy are the major factors bolstering the market.

What would be a prominent future trend in the doxorubicin market?

The increasing approval of generic products is likely to emerge as a significant trend in the market in the future.

Which are the leading players operating in the doxorubicin market?

Accord Healthcare, Cipla Inc., Dr. Reddy's Laboratories, Meiji Holdings Co. Ltd., Janssen Pharmaceuticals (Johnson and Johnson Services, Inc.), Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd, Baxter International Inc., Zydus Cadila are the leading players operating in the doxorubicin market.

What would be the estimated value of the doxorubicin market by 2031?

The estimated value of the market by 2031 will be US$ 2.35 billion.

What would be the expected CAGR of the doxorubicin market?

The market is estimated to record a CAGR of 6.1% during 2023–2031.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports